Abbott India Limited
ABBOTINDIA.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$553.05B
Close$
$62305.82
140.5% upside
Current Fair Value
140.5% upsideUndervalued by 140.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $553.05 Billion |
|---|---|
| Enterprise Value | $532.22 Billion |
| Dividend Yield | $656.00 (2.52%) |
| Earnings per Share | $730.37 |
| Beta | 0.06 |
| Outstanding Shares | 21,249,302 |
Return
| Return on Equity | 33.82% |
|---|---|
| Return on Assets | 24.83% |
| Return on Invested Capital | 41.95% |
Valuation & Multiples
| P/E Ratio | 34.22 |
|---|---|
| PEG | 199.79 |
| Price to Sales | 7.86 |
| Price to Book Ratio | 11.53 |
| Enterprise Value to Revenue | 7.6 |
| Enterprise Value to EBIT | 25.25 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$203.65
Average shareholder expectationRevenue Estimate
$18.89 B
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$212.40
Average shareholder expectationRevenue Estimate
$18.65 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Abbott India Limited
3,749 employees
CEO: Kartik Rajendran Abbott India Limited is an Indian pharmaceutical enterprise primarily engaged in the development and distribution of a diverse range of medicinal products. Its extensive portfolio addresses critical therapeutic areas such as women's heal...